Single-cell study finds shared epigenetic signature in breast tumours
In short
- Single-cell epigenetic analyses found a signature shared across patients.
- The signature may help identify patients at increased risk of relapse.
- The paper says it may help; it does not describe a tool already in clinical use.
Why it's good news
Relapse risk shapes how aggressively breast cancer is treated after surgery. A signature shared across patients could help match care to those most at risk, if it holds up. This is research so far, and any clinical use would need further testing.
Advertisement
From Nature
Nature, Published online: 11 November 2026; doi:10.1038/s41586-026-11230-y Single-cell epigenetic analyses reveal a conserved epigenetic signature across patients that may help identify those at increased risk for disease relapse in breast cancer.
Ask this story
More like this
Advertisement